Featured Research

from universities, journals, and other organizations

Software prevents depression during and after pregnancy, study finds

Date:
November 12, 2012
Source:
Asociación RUVID
Summary:
Despite 6 to 8 percent of women in Spain suffering depression during and after pregnancy, there are few effective tools for early detection and treatment. Researchers in Spain are working on developing a psychological on-line assessment tool to detect and prevent emotional disturbances during pregnancy and after childbirth. It is a tool that through Internet will assess, diagnose and, in the future, intervene, in cases of prenatal and postnatal depression.

Despite 6 to 8% of women in Spain suffering depression during and after pregnancy, there are few effective tools for early detection and treatment. Researchers at the Universitat Jaume I of Castellón and the University of Zaragoza, in collaboration with professionals from different health centres in Spain, are working on developing a psychological on-line assessment tool to detect and prevent emotional disturbances during pregnancy and after childbirth. It is a tool that through Internet will assess, diagnose and, in the future, intervene, in cases of prenatal and postnatal depression.

Early detection of the likelihood of developing these emotional changes could reduce both the impact of mental illness in the mother and a negative impact on physical and emotional development of the fetus and also reduce healthcare costs. The tool also aims to provide the most appropriate professional assistance for pregnant women comfortably, quickly and easily through the Internet. The project's main researcher, Jorge Osma, explains that the tool can be applied in both public and private centres and is a pioneering experience in Spain.

The application, called "MamáFeliz" Happy mother, is currently at the field study phase with a hundred pregnant women in the Valencian region and Aragón testing it. New participants will be incorporated through the collaboration of centres of Castilla y León, Madrid, Cataluña and Andalucía. The computer application (www.mamafeliz.es) allows measuring risk factors of emotional disorders. Besides psychological aspects, MamáFeliz also tracks information of sociodemographic, clinical and obstetric relevance, and offers the participant the results that show her emotional state. "So far all the variables that predispose a woman to depression during or after pregnancy had not been combined" says Osma.

The first results of the research show 48% of women had had previous depressions, which increases the risk of relapse, and 20% began to have symptoms of depression during pregnancy." Another significant risk factor present in 48% of the cases is, according Osma, feelings of ambivalence. "Sometimes they experience positive emotions related to pregnancy and childbirth, and other times, negative thoughts like fear, anxiety or doubt." The most frequent stressful life events are changes in economic conditions and changes in sleep habits, followed by changes in living or working conditions.

Other psychosocial variables that appear as risk factors in the scientific literature on the subject are the presence of psychopathologies in the mother or family, sociodemographic or obstetric variables, lack of social support, lack of partner or couple problems, increased life stress, substance abuse, past abortions, unintended pregnancies, anxiety towards the fetus, low self-esteem, low income, medical/physical problems during pregnancy and low capacity to cope with changes, among others.

In a new phase, the tool will also provide prevention and intervention applications. Cybertherapy or on-line therapy is emerging as a complement and an alternative to traditional counselling. "The British health system, for example, already integrates applications and on-line therapy for the treatment of depression," explains Osma.

Pregnant women interested in taking part in the study may do so through collaborating health centres in Castellón or contacting the team directly through the web www.mamafeliz.es. After receiving an access code, they may complete the questionnaires. Participants will know their emotional state and automatically enter a draw for different gifts.


Story Source:

The above story is based on materials provided by Asociación RUVID. Note: Materials may be edited for content and length.


Cite This Page:

Asociación RUVID. "Software prevents depression during and after pregnancy, study finds." ScienceDaily. ScienceDaily, 12 November 2012. <www.sciencedaily.com/releases/2012/11/121112090036.htm>.
Asociación RUVID. (2012, November 12). Software prevents depression during and after pregnancy, study finds. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/11/121112090036.htm
Asociación RUVID. "Software prevents depression during and after pregnancy, study finds." ScienceDaily. www.sciencedaily.com/releases/2012/11/121112090036.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins